Lanxess AG · XETR:LXS
Lanxess — Q1 2011 Earnings Presentation
41 slides from Lanxess's earnings presentation, Nov 26, 2011
Slide 1: LANXESS – Q1 2011 Roadshow: Excellent start 2011
LANXESS – Q1 2011 Roadshow Excellent start 2011 Dr. Axel C. Heitmann, CEO
Slide 2: Safe harbor statement
Safe harbor statement This presentation contains certain forward-looking statements, including assumptions, opinions and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, develo
Slide 3: Agenda
Agenda Strategy summary and executive overview Q1 2011 Business and financial review Q1 2011 Outlook/Guidance Chart 3
Slide 4: Portfolio management strengthens the company
Portfolio management strengthens the company Divested Year Leadership Cyclicality Profitability Acquired Position Expectation Fibers 2005 Weak High Low Paper 2005 Moderate Moderate Medium Textile Processing Chem. 2006 Weak Moderate Medium Lustran Polymers 2007 Good High Low CISA (LEA) 2006 Good Low
Slide 5: LANXESS acquired DSM Elastomers – strong financials and fast integration
LANXESS acquired DSM Elastomers – strong financials and fast integration Financial highlights EPDM - estimated production volume2 [kt] Purchase price: €310 m (EV); ~6x EBITDA Exxon Mobil pre1 Dow Cash and debt free DSM EPDM Financing out of existing liquidity LANXESS Mitsui Chemicals Lion Copo
Slide 6: Darmex – Provider of tailor-made products for the tire industry
Darmex – Provider of tailor-made products for the tire industry Darmex – Focusing on tire applications Product split Overview: Chemicals ~5% Founded in 1971 Bladders Privately owned company Release ~30% agents ~200 permanent employees worldwide ~65% Only global bladder producer able to also
Slide 7: Acquisition of Syngenta's Material Protection business
Acquisition of Syngenta’s Material Protection business: high margin business with long-term access to Syngenta’s R&D pipeline Active ingredients registration value chain Upstream integration into active ingredients End uses: Wood protection, Crop specific Final registration coatings, wallboard
Slide 8: Organic growth through ongoing targeted investments
Organic growth through ongoing targeted investments Investment projects (scheduled to come on stream) Q1 2013 2011 Q1 2011 - Q1 2012 H1 2012 Beginning 2012 BTR: SCP: Nd-PBR: BAC: SCP: New world Add. compounding Debottlenecking, New Formalin New compounding plant, scale plant, capacities, Orange, US
Slide 9: In 2015 LANXESS will strive for an EBITDA of ~€1.4 billion
In 2015 LANXESS will strive for an EBITDA of ~€1.4 billion New EBITDA target bridge [€ m] Performance Polymers Additional EBITDA will be the BTR Singapore and debottlenecking result of: PBR debottlenecking of Nd-PBR SCP caprolactam and compounding - announced CAPEX projects Advanced Intermed
Slide 10: LANXESS with excellent start in 2011
LANXESS with excellent start in 2011 Price increase offset sharply risen input costs Price before Business volume Strong volume growth across all regions intact Delivery on M&A: - Acquisition of DSM’s EPDM business closed with economic effect on May 1st On track to achieve Growth - Acquisition of Da
Slide 11: All segments manage price and volume increases in tandem
All segments manage price and volume increases in tandem Q1 yoy sales variances Price Volume Currency Portf. Total Performance Polymers 22% 11% 1% 0% 35% Successful pricing initiatives across the board Advanced Intermediates 9% 12% 1% 0% 22% Double digit volume increase in each segment reflects
Slide 12: Strong growth across all regions
Strong growth across all regions Q1 sales by region [%] Regional development of sales [€ m] Operational 2,073 development* Asia Germany 20% 461 22 19 1,613 +23% Asia 244 22% 376 +25% LatAm 328 195 29% +31% North America 250 LatAm 642 12 +33% 32% EMEA 484 (excl. Germany) EMEA North (excl. Germany) 29
Slide 13: Agenda
Agenda Strategy summary and executive overview Q1 2011 Business and financial review Q1 2011 Outlook/Guidance Chart 13
Slide 14: Q1 2011 financials: strong quarter despite raw material price inflation
Q1 2011 financials: strong quarter despite raw material price inflation [€ m] Q1 2010 Q1 2011 yoy in % Sales increase due to pricing Sales 1,613 2,073 28.5% power and strong volumes EBITDA pre except. 233 322 38.2% reflecting excellent market margin 14.4% 15.5% positions and premium offerings Vi
Slide 15: Strong demand and tight cost control yield an excellent quarter
Strong demand and tight cost control yield an excellent quarter [€ m] Q1 2010 Q1 2011 yoy in % Sales 1,613 (100%) 2,073 (100%) 29% Sales increased 29% on the Cost of sales -1,219 (76%) -1,551 (75%) 27% back of strong price (+15%) and volume (+12%) increases and Selling -142 (9%) -170 (8%) 20% some
Slide 16: Q1 2011 – Performance Polymers driving sales, EBITDA and margin increase
Q1 2011 – Performance Polymers driving sales, EBITDA and margin increase Sales Q1 2010 [€ m] Q1 2011 All three segments post 1,084 higher sales 1200 1000 800 806 Performance Polymers 556 600 416 455 with strongest increase 342 400 200 0 Performance Polymers Advanced Intermediates Performance Che
Slide 17: Performance Polymers: excellent start of the year
Performance Polymers: excellent start of the year [€ m] Q1 2010 Q1 2011 Price increases in all BUs, offsetting Butadiene- / Sales 806 1,084 Cyclohexane-driven raw material price increase EBIT 96 165 BTR with ongoing strong demand, PBR with positive mix effect Depr. / Amort. 34 34 TRP rubbers N
Slide 18: TRP offers a broad solution portfolio for many applications
TRP offers a broad solution portfolio for many applications TRP part of Performance Polymers Specialty elastomers for rubber Main competitors: Denka, DuPont, Production: Germany, France, U.S. processing industry Exxon Mobil, JSR, Kumho, Polimeri Sales > €500 m, customers > 600 Used in au
Slide 19: Advanced Intermediates: agro-business drives earnings
Advanced Intermediates: agro-business drives earnings [€ m] Q1 2010 Q1 2011 Price increases compensate significant raw material price Sales 342 416 inflation (Benzene) EBIT 43 59 Overall strong volumes based on agro-related demand Depr. / Amort. 14 16 BAC with continued improvement of demand f
Slide 20: Performance Chemicals: strong volume and price performance
Performance Chemicals: strong volume and price performance [€ m] Q1 2010 Q1 2011 Volume and price developments lead to stronger sales, raw Sales 455 556 materials offset by price increases EBIT 62 72 RUC, FCC and RCH strongest contributors to volume increase Depr. / Amort. 16 18 IPG with highe
Slide 21: Strong financial backbone for growth
Strong financial backbone for growth [€ m] Dec 31, 2010 Mar 31, 2011 Dec 31, 2010 Mar 31, 2011 Non-current Assets 2,738 2,719 Stockholders’ Equity 1,761 1,917 Intangible assets 226 238 Non-current Liabilities 2,454 2,445 Property, plant & equipment 2,131 2,086 Pension & post empl. provis. 605 610 Eq
Slide 22: Strong operating cash generation
Strong operating cash generation [€ m] Q1 2010 Q1 2011 Profit before Tax 144 219 Cash flow fueled by demand Depreciation & amortization 66 71 momentum Gain from sale of assets 0 0 Working capital increase driven Result from equity investments -4 -5 by higher receivables and Financial losses 21 2
Slide 23: Agenda
Agenda Strategy summary and executive overview Q1 2011 Business and financial review Q1 2011 Outlook/Guidance Chart 23
Slide 24: LANXESS is optimistic for 2011 – earnings growth 10-15%
LANXESS is optimistic for 2011 – earnings growth 10-15% Current macro view Growth in emerging markets will continue Western markets develop at lower pace Macroeconomic challenges: geopolitical unrest, national deficits, US dollar weakness, potential impact after natural disasters in Japan LANX
Slide 25: LANXESS – Energizing Chemistry
LANXESS nergizing Chemistry
Slide 26: Appendix
x Oo = 7) ok oF <x
Slide 27: 2011 financial expectations
2011 financial expectations Additional financial expectations for 2011 Capex : ~€550-600 m D&A : ~€300 – €320 m incl. acquisition Tax rate : 20 to 25% Hedging 2011 : ~40% at 1.30-1.40 USD / EUR Exceptionals : minor for ongoing businesses, excluding acquisitions Chart 27
Slide 28: Portfolio management allows regrouping of LANXESS businesses along chemical segmentation
Portfolio management allows for regrouping of LANXESS businesses along chemical segmentation Performance Polymers Performance Polymers Advanced Intermediates Performance Chemicals Butyl Rubber Basic Chemicals Material Protection Products Performance Butadiene Rubbers Saltigo Inorganic Pigments Techn
Slide 29: LANXESS has a broad customer portfolio with varying demand patterns
LANXESS has a broad customer portfolio with varying demand patterns LANXESS sales distribution by industry, 2010 Others Tires Construction Agro Automotive Chemicals Consumer Goods Chart 29
Slide 30: Tire producers are reacting swiftly
Tire producers are reacting swiftly Bridgestone China: plus ~11 m car tires/year Russia: plus ~1.4 m car tires/year USA: USD$11.3 m expansion of USD$347 m investment in Russia USA: plus ~3 m tires/year aviation tire capacity Philippines:plus ~6 m tires/year USD$2.2 b expansion in Brazi
Slide 31: Similar tire labelings are being proposed in several countries
Similar tire labelings are being proposed in several countries Tire labels Europe U.S. Japan For fuel efficient tires For fuel efficient tires Chart 31
Slide 32: Is LANXESS a swing producer?
Is LANXESS a swing producer? Tire manufacturers produce insufficient synthetic rubber for their captive use Rubber producing capabilities of selected tire manufacturers: Importance in LANXESS Michelin Goodyear Bridgestone Continental Pirelli Hankook portfoIlio major BTR none none none none none none
Slide 33: Does natural rubber cannibalize synthetic rubber?
Does natural rubber cannibalize synthetic rubber? Risk of substitution Low substitution risk High substitution risk BTR PBR1 S-SBR E-SBR NBR EPDM Overall, very limited substitution possibility 1 Nd-PBR Chart 33
Slide 34: Strategic step to broaden global position as integrated service provider for tire producers
Strategic step to broaden global position as integrated service provider for tire producers Financial details Products EPS accretive in 2011 Activators Transaction will close as of Release Agents January, 2011 Other rubber additives Bladders Financing of acquisition out …. of existing liquidit
Slide 35: Segment change: transfer of Adipic acid from BU SCP to BU BAC
Segment change: transfer of Adipic acid from BU SCP to BU BAC Value chain* optimized Rationale KA-oil, adipic acid and hexandiol now part of one single business Performance Polymers Adv. Interm. unit (BU BAC) external Adipic Hexane- external Business line adipic acid, easy RM KA-oil sales acid d
Slide 36: Business line Adipic Acid shifted to BU BAC
Business line Adipic Acid shifted to BU BAC Adipic Acid used captively and for external sales Business line Adipic Acid transferred from Performance Polymers to Advanced Intermediates Originally located in BU SCP, In € m Q1 2010 Adipic Acid sales split now part of BU BAC into: External sales
Slide 37: Steep increase in raw material prices expected
Steep increase in raw material prices expected Global raw materials index* Raw material prices increased [%] beginning of 2010 160 Q3 and Q4 ’10 with a relatively 150 stable raw material price development 140 Q1 saw feedstock prices 130 (mainly butadiene, benzene 120 and cyclohexane) rise, fee
Slide 38: Exceptional items incurred in Q1 2010 and Q1 2011
Exceptional items incurred in Q1 2010 and Q1 2011 [€ m] Q1 2010 Q1 2011 Exceptional thereof D&A Exceptional thereof D&A Performance Polymers 1 0 0 0 Advanced Intermediates 0 0 0 0 Performance Chemicals 0 0 0 0 Reconciliation 2 0 5 0 Total 3 0 5 0 Chart 38
Slide 39: Abbreviations
Abbreviations Performance Polymers Advanced Intermediates BTR Butyl Rubber BAC Basic Chemicals PBR Performance Butadiene Rubbers SGO Saltigo TRP Technical Rubber Products SCP Semi-Crystalline Products Performance Chemicals MPP Material Protection Products IPG Inorganic Pigments FCC
Slide 40: Upcoming events 2011
Upcoming events 2011 Upcoming events Annual Stockholders’ Meeting May 18, 2011 Q2 Results 2011 August 11, 2011 Analyst round table September 22, 2011 Q3 Results 2011 November 10, 2011 Chart 40
Slide 41: Contact detail Investor Relations
Contact detail Investor Relations Oliver Stratmann Verena Simiot Head of Investor Relations Assistant Investor Relations Tel. : +49-214 30 49611 Tel. : +49-214 30 23851 Fax. : +49-214 30 959 49611 Fax. : +49-214 30 40944 Mobile : +49-175 30 49611 Mobile : +49-175 30 23851 Email : Oliver.Stratmann@la